[HTML][HTML] Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells

VN Dedov, IV Dedova, AH Merrill Jr… - Biochimica et Biophysica …, 2004 - Elsevier
VN Dedov, IV Dedova, AH Merrill Jr, GA Nicholson
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2004Elsevier
Hereditary sensory neuropathy type I (HSN1) is a common degenerative disorder of
peripheral sensory neurons. HSN1 is caused by mutations in the gene, encoding the long
chain base 1 of serine palmitoyltransferase (SPT)[Nat. Genet. 27 (2001) 309]. Here, we
show a 44% reduction of SPT activity in transformed lymphocytes from HSN1 patients with
mutation T399G in the SPTLC1 gene. However, the decrease in SPT activity had no effect
on de novo sphingolipid biosynthesis, cellular sphingolipid content, cell proliferation and …
Hereditary sensory neuropathy type I (HSN1) is a common degenerative disorder of peripheral sensory neurons. HSN1 is caused by mutations in the gene, encoding the long chain base 1 of serine palmitoyltransferase (SPT) [Nat. Genet. 27 (2001) 309]. Here, we show a 44% reduction of SPT activity in transformed lymphocytes from HSN1 patients with mutation T399G in the SPTLC1 gene. However, the decrease in SPT activity had no effect on de novo sphingolipid biosynthesis, cellular sphingolipid content, cell proliferation and death (apoptosis and necrosis). The removal of extracellular sphingolipids did not affect viability of HSN1 cells. We also found no significant difference in whole blood counts, viability, and permeability to Triton X-100 of primary lymphocytes from HSN1 patients. These results suggest that, despite the inhibition of mutant allele, the activity of nonmutant allele of STP may be sufficient for adequate sphingolipid biosynthesis and cell viability. Therefore, the neurodegeneration in HSN1 is likely to be caused by subtler and rather long-term effect(s) of these mutations such as loss of a cell-type selective facet of sphingolipid metabolism and/or function, or perhaps accumulation of toxic species, including abnormal protein(s) as in other neurodegenerations.
Elsevier